Sort
11,323 grants matching “glioblastoma”
Chlorotoxin as a Targeting Agent for Cancer Therapies
$396,000James M Olson · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Chlorotoxin as a Targeting Agent for Cancer Therapies
$396,000James M Olson · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
$395,960Maria G Castro · University Of Michigan At Ann Arbor · R37 · FY2015 · NS
Novel RTK Targeting Strategies in Glioblastoma
$395,913Roger Abounader · University Of Virginia · R01 · FY2013 · NS
Transfer of microRNA regulators from glioblastoma to brain microenvironment
$395,879Xandra Owens Breakefield · Massachusetts General Hospital · U19 · FY2015 · CA
Development of murine glioblastoma model for oncolytic HSV therapy
$395,812Balveen Kaur · Augusta University · R61 · FY2024 · NS
Investigating and Targeting TAMs in the Glioma Microenvironment
$395,775Johanna Joyce · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Targeting tumorigenic pathways in glioblastoma with oncolytic HSV
$395,770Samuel D Rabkin · Massachusetts General Hospital · R01 · FY2020 · CA
Targeting tumorigenic pathways in glioblastoma with oncolytic HSV
$395,770Samuel D Rabkin · Massachusetts General Hospital · R01 · FY2019 · CA
Targeting tumorigenic pathways in glioblastoma with oncolytic HSV
$395,770Samuel D Rabkin · Massachusetts General Hospital · R01 · FY2021 · CA
Modeling and druggable-genome screening of glioblastoma invasion using regional biopsy-guided biomaterials systems
$395,717Manish Aghi · University Of California, San Francisco · R01 · FY2022 · CA
Growth inhibition of brain tumors by cord blood stem cells
$395,622Jasti S Rao · University Of Illinois At Chicago · R01 · FY2006 · NS
The DNA Damage Response and Tumorigenesis in the Brain
$395,457Peter J McKinnon · St. Jude Children'S Research Hospital · P01 · FY2019 · CA
Using siRNAs against tau circular RNAs as a rational therapy for Alzheimer's disease
$395,248Stefan Stamm · Circcure Corporation · R41 · FY2022 · AG
Small Molecule Activators of Procaspases as Anti-Cancer Agents
$395,217Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2022 · CA
Novel adoptive transfer therapy for glioma using CAR-transduced Type17 T-cells
$395,208Hideho Okada · University Of California, San Francisco · R21 · FY2014 · NS
miRNA and v-Cdks: Independent Drivers OF EBV and HCMV Replication and Oncogenesi
$395,189Shannon Celeste Kenney · University Of Wisconsin-Madison · P01 · FY2015 · CA
Activation and Regulation of the Understudied Kinome Using MIB/MS Technology
$395,126Gary L. Johnson · Univ Of North Carolina Chapel Hill · U01 · FY2016 · MH
Activation and Regulation of the Understudied Kinome Using MIB/MS Technology
$395,126Gary L. Johnson · Univ Of North Carolina Chapel Hill · U01 · FY2015 · MH
TOP2A effects on transcription in gliomas: implications for personalized therapy
$395,000Adam M Sonabend · Northwestern University At Chicago · DP5 · FY2019 · OD
TOP2A effects on transcription in gliomas: implications for personalized therapy
$395,000Adam M Sonabend · Northwestern University At Chicago · DP5 · FY2017 · OD
TOP2A effects on transcription in gliomas: implications for personalized therapy
$395,000Adam M Sonabend · Northwestern University At Chicago · DP5 · FY2018 · OD
Neural Stem Cell Carriers for Glioblastoma Immunotherapy
$394,803Irina V Balyasnikova · Northwestern University At Chicago · R33 · FY2019 · NS
S100A4 mediated immune suppression in GBM
$394,788Kyuson Yun · Methodist Hospital Research Institute · R01 · FY2025 · NS
Establishing the validity of brain tumor perfusion imaging
$394,763Christopher Chad Quarles · St. Joseph'S Hospital And Medical Center · R01 · FY2021 · CA